sildenafil-citrate and Splenic-Diseases

sildenafil-citrate has been researched along with Splenic-Diseases* in 1 studies

Other Studies

1 other study(ies) available for sildenafil-citrate and Splenic-Diseases

Article	Year
[Dyspnea secondary to pulmonary hypertension in a patient with splenic myeloid metaplasia]. La Revue de medecine interne, 2009, Volume: 30, Issue:9 There are several possible pathophysiological links between the development of pulmonary hypertension and myelofibrosis with myeloid metaplasia. We report a woman with myelofibrosis and myeloid metaplasia who presented with dyspnea and massive, painful splenomegaly. Right heart catheterization evidenced pulmonary hypertension. Her management consisted of splenic irradiation associated to sildenafil. Dyspnea in patients with myelofibrosis and myeloid metaplasia can be secondary to pulmonary hypertension and conversely the differential diagnosis of pulmonary hypertension should include a myeloproliferative syndrome. Topics: Anticoagulants; Cardiac Catheterization; Diagnosis, Differential; Diuretics; Drug Therapy, Combination; Dyspnea; Echocardiography, Doppler; Electrocardiography; Female; Fibrinolytic Agents; Furosemide; Heparin, Low-Molecular-Weight; Humans; Hypertension, Pulmonary; Middle Aged; Myeloproliferative Disorders; Palliative Care; Phosphodiesterase Inhibitors; Piperazines; Primary Myelofibrosis; Purines; Sildenafil Citrate; Splenic Diseases; Splenomegaly; Sulfones; Vasodilator Agents	2009

Article

Year

[Dyspnea secondary to pulmonary hypertension in a patient with splenic myeloid metaplasia].

La Revue de medecine interne, 2009, Volume: 30, Issue:9

There are several possible pathophysiological links between the development of pulmonary hypertension and myelofibrosis with myeloid metaplasia. We report a woman with myelofibrosis and myeloid metaplasia who presented with dyspnea and massive, painful splenomegaly. Right heart catheterization evidenced pulmonary hypertension. Her management consisted of splenic irradiation associated to sildenafil. Dyspnea in patients with myelofibrosis and myeloid metaplasia can be secondary to pulmonary hypertension and conversely the differential diagnosis of pulmonary hypertension should include a myeloproliferative syndrome.

Topics: Anticoagulants; Cardiac Catheterization; Diagnosis, Differential; Diuretics; Drug Therapy, Combination; Dyspnea; Echocardiography, Doppler; Electrocardiography; Female; Fibrinolytic Agents; Furosemide; Heparin, Low-Molecular-Weight; Humans; Hypertension, Pulmonary; Middle Aged; Myeloproliferative Disorders; Palliative Care; Phosphodiesterase Inhibitors; Piperazines; Primary Myelofibrosis; Purines; Sildenafil Citrate; Splenic Diseases; Splenomegaly; Sulfones; Vasodilator Agents

2009